Intelicanna Stock Fundamentals
| INTL Stock | 57.80 5.90 9.26% |
Intelicanna fundamentals help investors to digest information that contributes to Intelicanna's financial success or failures. It also enables traders to predict the movement of Intelicanna Stock. The fundamental analysis module provides a way to measure Intelicanna's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelicanna stock.
Intelicanna |
Intelicanna Company Operating Margin Analysis
Intelicanna's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Intelicanna Operating Margin | (2.86) % |
Most of Intelicanna's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelicanna is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Intelicanna has an Operating Margin of -2.864%. This is 91.84% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers-Specialty & Generic industry. The operating margin for all Israel stocks is 48.02% lower than that of the firm.
Intelicanna Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intelicanna's current stock value. Our valuation model uses many indicators to compare Intelicanna value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intelicanna competition to find correlations between indicators driving Intelicanna's intrinsic value. More Info.Intelicanna is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Intelicanna by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intelicanna's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Intelicanna Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelicanna's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelicanna could also be used in its relative valuation, which is a method of valuing Intelicanna by comparing valuation metrics of similar companies.Intelicanna is currently under evaluation in operating margin category among its peers.
Intelicanna Fundamentals
| Return On Equity | -3.48 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (2.86) % | |||
| Current Valuation | 64.57 M | |||
| Shares Outstanding | 46.96 M | |||
| Shares Owned By Insiders | 34.65 % | |||
| Price To Sales | 4.14 X | |||
| Revenue | 4.21 M | |||
| Gross Profit | (9.19 M) | |||
| EBITDA | (10.67 M) | |||
| Net Income | (14.64 M) | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (15.38 M) | |||
| Earnings Per Share | (0.33) X | |||
| Number Of Employees | 40 | |||
| Beta | -0.89 | |||
| Market Capitalization | 17 M |
About Intelicanna Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelicanna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelicanna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelicanna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Intelicanna Stock
Intelicanna financial ratios help investors to determine whether Intelicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intelicanna with respect to the benefits of owning Intelicanna security.